Travel Grant, 2025, South Korea, Bio Korea, May 6-9
Reference number | |
Coordinator | Salipro Biotech AB |
Funding from Vinnova | SEK 25 000 |
Project duration | May 2025 - May 2025 |
Status | Completed |
Venture | Global cooperation 2025 |
Important results from the project
The project successfully met its initial objectives, including expanding Salipro Biotech’s presence in South Korea, reinforcing existing partnerships, and initiating the discussions of new collaboration opportunities. Additional outcomes included enhanced visibility through presentations and meetings, the establishment of new industry key contacts, and strategic insights that support our long-term strategic growth and contribute to Sweden’s global life science positioning.
Expected long term effects
In the long term, the project is expected to facilitate sustained international collaborations, particularly in South Korea, through strengthened partnerships and new strategic alliances. These relationships may lead to co-development projects and licensing opportunities in the context of Salipro® platform. The outcomes also support Salipro Biotech’s global expansion and contribute to Sweden’s role as a leader in life science innovation and international cooperation.
Approach and implementation
The project was carried out according to plan, with a strong focus on promoting Swedish life sciences—including Salipro Biotech’s presence—in South Korea. Activities such as strategic preparation, targeted networking, meetings, presentations and site visits were well-aligned with the goals. The timeline was followed, no major external issues arose, and the delegation program exceeded expectations by generating new leads and expanding professional networks. Overall the project was successful.